Vitamin C is best known as a nutrient. In high enough doses, however, vitamin C also shows potential against many cancers, according to recent studies. To successfully develop vitamin C (chemically named ascorbic acid) as a medication, it is crucial to probe its concentration in the body, thus ensuring safe and effective doses.
Monitoring the changing levels of a delivered drug is not easy. For ascorbic acid, one method is to use the reaction between the compound and fluorescent probe molecules, allowing chemists to visually trace its movement through the body. Fluorescence requires light, however, and existing probes use light of the wrong wavelength to penetrate living tissue. Now, a research team has developed a new probe that could shine a path to ascorbic acid as a cancer treatment.
In a study reported in Scientific Reports, ascorbic acid levels in mice were tracked using a complex molecule called R2c. Using some clever chemistry, the team designed this probe to react with ascorbic acid molecules in the body. An hour after R2c was injected into mice's tails, the entire body was fluorescent, highlighting the ascorbic acid naturally present in the mice, as the R2c probe was circulating through the bloodstream.
Next, the mice were injected with a dose of extra ascorbic acid, raising the concentration above normal. Within 10 minutes, the fluorescence signal flared up in the abdomen - showing that this was the first destination of the ascorbic acid dose flowing from the tail. Like before, the probe signal then spread throughout the body over the next hour, becoming particularly intense in vital organs. This is the first time that researchers have directly imaged ascorbic acid administered to a mouse.
The probe is highly sensitive, detecting ascorbic acid down to micromolar amounts - enough level for detecting it in the human blood. As study first author explains, "We created R2c from a silicon compound, SiPc, bonded to TEMPO free radicals. The radicals stop SiPc molecules from aggregating, which would switch off their fluorescence. In turn, each probe molecule is encapsulated in a protein called BSA."
By blocking reactions with chemicals other than the target, BSA ensures that the probe is also selective. R2c reacts rapidly with ascorbic acid, becoming a fluorescent molecule - but it remains sternly aloof to other biological compounds. The team found that hydrogen peroxide, which occurs in the body, could be added to R2c without interfering with the ascorbic acid signal - at least in the lab. This raises the hope that R2c could faithfully pick out ascorbic acid in human patients as well.
"Our probe is the first to trace vitamin C with sensitivity as well as speed, selectiveness, and low toxicity," corresponding author says. "Excitingly, we could watch exactly which organs the vitamin C accumulated in. For clinical cancer treatment, that would be a priceless help to efficiently deliver this drug to the right parts of the body."
https://www.iis.u-tokyo.ac.jp/en/news/2849/
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
Mouse pups with human mutation show signs of stuttering
Read more
Mechanism behind brains derailed train of thought
Read more
Effect of progressive weight loss on metabolic functions
Read more
Alcohol exposure during pregnancy affects multiple generations
Read more
Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Deriv…
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar